We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Novel Hydrogel: Targeted Delivery of Drugs for Rheumatoid Arthritis Patients

News   Oct 12, 2017 | Original story from the Institute for Basic Research

 
Novel Hydrogel: Targeted Delivery of Drugs for Rheumatoid Arthritis Patients

IBS scientists developed a hydrogel made of polymeric acrylamide (blue spaghetti) linked with crosslinkers (black), which can accommodate drug molecules (purple stars) within its mesh (grey). In the presence of nitric oxide (red), the linker is cleaved and the drug molecules can be released. At the same time, the gel absorbs fluid from the surroundings and swells in size. Image credit: Park J. et al, Advanced Materials (2017)

 
 
 

RELATED ARTICLES

Developing Pioneering Cell Therapies for Immunotherapy Non-responders

News

New research signposts a novel, less invasive method to identify killer T lymphocytes in patients with gastrointestinal tumors with low mutational burden who are refractory to currently-approved immune-based treatments.

READ MORE

Even Short-term Vaping Causes Inflammation in Non-smokers, says Pilot Study

News

Researchers report the first evidence of biological changes correlated with e-cigarette use in never-smokers.

READ MORE

Will a Next-generation Therapy for Diabetes Soon Be Available?

News

In order to improve diabetes therapy, researchers at the University of Geneva (UNIGE), Switzerland, have identified a protein called S100A9 which, under certain conditions, seems to act as a blood sugar and lipid regulator while avoiding the most harmful side effects of insulin.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE